Emerging Targeted Therapies for HER2-Positive Breast Cancer

por Mercogliano, María Florencia, Bruni, Sofía, Mauro, Florencia Luciana, Schillaci, Roxana
Publicado 2023

Tumor Necrosis Factor α Blockade: An Opportunity to Tackle Breast Cancer

por Mercogliano, María Florencia, Bruni, Sofía, Elizalde, Patricia V., Schillaci, Roxana
Publicado 2020

Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy

por Mercogliano, María Florencia, Bruni, Sofía, Mauro, Florencia, Elizalde, Patricia Virginia, Schillaci, Roxana
Publicado 2021

Cancer immune exclusion: breaking the barricade for a successful immunotherapy

por Bruni, Sofia, Mercogliano, María Florencia, Mauro, Florencia Luciana, Cordo Russo, Rosalia Inés, Schillaci, Roxana
Publicado 2023

Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development

por Rivas, Martin A, Venturutti, Leandro, Huang, Yi-Wen, Schillaci, Roxana, Huang, Tim Hui-Ming, Elizalde, Patricia V
Publicado 2012

Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth

por Izzo, Franco, Mercogliano, Florencia, Venturutti, Leandro, Tkach, Mercedes, Inurrigarro, Gloria, Schillaci, Roxana, Cerchietti, Leandro, Elizalde, Patricia V, Proietti, Cecilia J
Publicado 2014

ODP441 NErbB-2 and Androgen Receptor Regulate a Gene Signature Involved in Immune Response and Favorable Outcome in TNBC

por Elizalde, Patricia, Roldan Deamicis, Agustina, Oakley, Robert, Madera, Santiago, Cordo Russo, Rosalía, Schillaci, Roxana, Fresno, Cristóbal, Cidlowski, John, Proietti, Cecilia
Publicado 2022

Small Interfering RNA Targeted to IGF-IR Delays Tumor Growth and Induces Proinflammatory Cytokines in a Mouse Breast Cancer Model

por Durfort, Tiphanie, Tkach, Mercedes, Meschaninova, Mariya I., Rivas, Martín A., Elizalde, Patricia V., Venyaminova, Alya G., Schillaci, Roxana, François, Jean-Christophe
Publicado 2012

ODP438 Canonical and Non-canonical Function of EZH2 in Progesterone Receptor Target Genes in Breast Cancer

por Elizalde, Patricia, Belmonte, Martina, Cenciarini, Mauro, Deamicis, Agustina Roldan, Madera, Santiago, Mercogliano, Florencia, Mauro, Florencia, Bruni, Sofia, Russo, Rosalía Cordo, Schillaci, Roxana, Proietti, Cecilia
Publicado 2022

Halting Retrograde Transport Excludes ErbB-2 From the Nucleus Abrogating Tumor Growth in Triple Negative Breast Cancer

por Madera, Santiago, Izzo, Franco, Chervo, María Florencia, Dupont, Agustina, Chiauzzi, Violeta Alicia, Montero, Diego, Deamicis, Agustina Roldán, Proietti, Cecilia Jazmín, Schillaci, Roxana, Elizalde, Patricia Virginia, Russo, Rosalia Ines Cordo
Publicado 2021

Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancer

por Schillaci, Roxana, Guzmán, Pablo, Cayrol, Florencia, Beguelin, Wendy, Díaz Flaqué, María C, Proietti, Cecilia J, Pineda, Viviana, Palazzi, Jorge, Frahm, Isabel, Charreau, Eduardo H, Maronna, Esteban, Roa, Juan C, Elizalde, Patricia V
Publicado 2012

FXYD5/Dysadherin, a Biomarker of Endometrial Cancer Myometrial Invasion and Aggressiveness: Its Relationship With TGF-β1 and NF-κB Pathways

por Besso, María José, Rosso, Marina, Lapyckyj, Lara, Moiola, Cristian Pablo, Matos, María Laura, Mercogliano, María Florencia, Schillaci, Roxana, Reventos, Jaume, Colas, Eva, Gil-Moreno, Antonio, Wernicke, Alejandra, Orti, Roberto, Vazquez-Levin, Mónica Hebe
Publicado 2019

Androgen Receptor Highjacks ErbB-2 Nuclear Function to Induce Triple Negative Breast Cancer Growth

por Deamicis, Agustina Roldán, Oakley, Robert H, Helguera, Sergio Andonegui, Lenze, Mariela B, Madera, Santiago, Russo, Rosalia I Cordo, Chervo, María F, Schillaci, Roxana, Fresno, Cristóbal, Cidlowski, John A, Elizalde, Patricia V, Proietti, Cecilia J
Publicado 2021

Inflammasome Activation Is Critical to the Protective Immune Response during Chemically Induced Squamous Cell Carcinoma

por Gasparoto, Thais Helena, de Oliveira, Carine Ervolino, de Freitas, Luisa Thomazini, Pinheiro, Claudia Ramos, Hori, Juliana Issa, Garlet, Gustavo Pompermaier, Cavassani, Karen Angélica, Schillaci, Roxana, da Silva, João Santana, Zamboni, Dario Simões, Campanelli, Ana Paula
Publicado 2014

Blockade of Stat3 oncogene addiction induces cellular senescence and reveals a cell-nonautonomous activity suitable for cancer immunotherapy

por De Martino, Mara, Tkach, Mercedes, Bruni, Sofía, Rocha, Darío, Mercogliano, María F., Cenciarini, Mauro E., Chervo, María F., Proietti, Cecilia J., Dingli, Florent, Loew, Damarys, Fernández, Elmer A., Elizalde, Patricia V., Piaggio, Eliane, Schillaci, Roxana
Publicado 2020

Nuclear ErbB-2-Induced Transcriptome Drives Triple Negative Breast Cancer Growth

por Chervo, Maria F, Parra, Micaela, Bellora, Nicolas, Petrillo, Ezequiel, Madera, Santiago, Deamicis, Agustina Roldan, Mitsuya, Kohzoh, Chiauzzi, Violeta A, Proietti, Cecilia J, Schillaci, Roxana, Huang, Tim H-M, Russo, Rosalia I Cordo, Elizalde, Patricia V
Publicado 2021

ODP551 Halting ErbB-2 Isoforms Retrograde Transport to the Nucleus as a New Theragnostic Approach for Triple Negative Breast Cancer

por Elizalde, Patricia Virginia, Izzo, Franco, Chervo, Maria Florencia, Merin, Sharon Salma, Dupont, Agustina, Chiauzzi, Violeta, Bruni, Sofia, Petrillo, Ezequiel, Montero, Diego, Mercogliano, Maria Florencia, Proietti, Cecilia Jazmin, Schillaci, Roxana, Madera, Santiago, Russo, Rosalia Ines Cordo
Publicado 2022

Retraction Note: Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs b...

por Flaqué, María C. Díaz, Galigniana, Natalia M., Béguelin, Wendy, Vicario, Rocío, Proietti, Cecilia J., Russo, Rosalía Cordo, Rivas, Martín A., Tkach, Mercedes, Guzmán, Pablo, Roa, Juan C., Maronna, Esteban, Pineda, Viviana, Muñoz, Sergio, Mercogliano, María Florencia, Charreau, Eduardo H., Yankilevich, Patricio, Schillaci, Roxana, Elizalde, Patricia V.
Publicado 2023

Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer grow...

por Díaz Flaqué, María C, Galigniana, Natalia M, Béguelin, Wendy, Vicario, Rocío, Proietti, Cecilia J, Russo, Rosalía Cordo, Rivas, Martín A, Tkach, Mercedes, Guzmán, Pablo, Roa, Juan C, Maronna, Esteban, Pineda, Viviana, Muñoz, Sergio, Mercogliano, María Florencia, Charreau, Eduardo H, Yankilevich, Patricio, Schillaci, Roxana, Elizalde, Patricia V
Publicado 2013

Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer

por Madera, Santiago, Izzo, Franco, Chervo, María F., Dupont, Agustina, Chiauzzi, Violeta A., Bruni, Sofia, Petrillo, Ezequiel, Merin, Sharon S., De Martino, Mara, Montero, Diego, Levit, Claudio, Lebersztein, Gabriel, Anfuso, Fabiana, Roldán Deamicis, Agustina, Mercogliano, María F., Proietti, Cecilia J., Schillaci, Roxana, Elizalde, Patricia V., Cordo Russo, Rosalía I.
Publicado 2022